Edwards Lifesciences has identified a potential safety risk which may occur during the use of the intraclude intra-aortic occlusion device (ICF100), used in cardiopulmonary bypass surgery. Edwards has received a limited number of reports regarding device damage on the strain relief near the hub area. Some of the reports have also indicated blood leakage in this area. When damage exists, blood loss can occur because blood can fill the device between the lumen shaft and the strain relief and leak from the area. No injuries or blood transfusions have been reported. In a worst case scenario with no mitigation, blood loss can occur during use of the device.